Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Alexion Pharmaceuticals

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
56/100
Moderate Influence
$7.3M
Total Lobby Spend
4
Policy Issues
5
Lobbyists
2
Revolving Door

Alexion Pharmaceuticals reported $7.3 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of State
Dept of Transportation
National Science Foundation
Office of Management & Budget
Centers for Medicare & Medicaid Services
Dept of Defense

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecS-3 Group
PHAHCRGOV
3$343K
2024 Jul-SepTarplin, Downs & Young
GOVHCRPHA+1
4$271K
2024 Apr-JunK&L Gates
MEDHCRPHA+1
1$290K
2024 Jan-MarVan Scoyoc Associates
GOVPHAMED
2$324K
2023 Oct-DecHogan Lovells
PHAMED
4$354K
2023 Jul-SepPeck Madigan Jones
GOVPHAHCR
2$320K
2023 Apr-JunSteptoe & Johnson
HCRPHAGOV
2$413K
2023 Jan-MarWilliams & Jensen
PHAGOV
3$414K

Alexion Pharmaceuticals Lobbying FAQ

Alexion Pharmaceuticals has spent $7.3M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Alexion Pharmaceuticals lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Alexion Pharmaceuticals has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Alexion Pharmaceuticals employs 5 registered lobbyists, of whom 2 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Alexion Pharmaceuticals has contacted 6 government entities as part of their lobbying activities, including Dept of State, Dept of Transportation, National Science Foundation.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.